Bai-jun Dong
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.
Journal: Nature communications
Published: December 18, 2023
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study.
Journal: Asian journal of andrology
Published: December 20, 2022
A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol.
Journal: Frontiers in oncology
Published: August 17, 2021
Wnt/β-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation.
Journal: Biochemical and biophysical research communications
Published: March 29, 2020
Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study.
Journal: Asian journal of andrology
Published: August 30, 2016
Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status.
Journal: Stem cell reports
Published: July 03, 2015
Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia.
Journal: Oncotarget
Published: October 22, 2014
SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis.
Journal: The Journal of pathology
Published: February 04, 2014
Discrepancy between radiological and pathological sizes of renal masses
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 15, 2013
Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: September 13, 2012
Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months.
Journal: Familial cancer
Published: December 29, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026